Discovery of 1,3,4-oxadiazoles with slow-action activity against Plasmodium falciparum malaria parasites
Andrews, K. T.; Fisher, G. M.; Firmin, M.; Liepa, A.; Wilson, T.; Gardiner, J.; Mohri, Y.; Rai, A.; Davey, A. K.; Masurier, A.; Delion, A.; Mouratidis, A. A.; Hutt, O.; Burrows, J. N.; Ryan, J. H.; Riches, A.; Skinner-Adams, T. S.
Show abstract
To achieve malaria eradication, new preventative agents that act differently to front-line treatment drugs are needed. To identify potential chemoprevention starting points we screened a sub-set of the CSIRO Australia Compound Collection for compounds with slow-action in vitro activity against Plasmodium falciparum. This work identified N,N-dialkyl-5-alkylsulfonyl-1,3,4-oxadiazol-2-amines as a new antiplas-modial chemotype (e.g., 1 96 h IC50 550 nM) with a different action to delayed-death slow-action drugs. Structure activity relationship analysis of analogues identified multiple compounds with potent and selective in vitro activity against drug-sensitive and multi-drug resistant Plasmodium parasites (e.g., 31 and 32 96 h IC50 <40 nM; SI >2,500). However subsequent studies in mice with lead compound 1, which had the best microsomal stability of the compounds assessed, demonstrated rapid clearance (T1/2 <1.6 h) and poor oral in vivo efficacy. This indicates that improvements in the pharmacokinetic profile of N,N-dialkyl-5-alkylsulfonyl-1,3,4-oxadiazol-2-amines would be needed for the development of this chemotype for malaria chemoprophylaxis.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Structure-Uptake Relationship Studies of Oxazolidinones in Gram-negative ESKAPE Pathogens 99%
- A Systematic Survey of Reversibly Covalent Dipeptidyl Inhibitors of the SARS-CoV-2 Main Protease 99%
- Exploring heteroaromatic rings as a replacement for the labile amide of antiplasmodial pantothenamides 98%
Similar papers in this journal
- Substitutions at the C-8 position of quinazolin-4-ones improve the potency of nicotinamide site binding tankyrase inhibitors 99%
- Discovery of novel 1,4-dicarbonylthiosemicarbazides as DNA gyrase inhibitors for the treatment of MRSA infection 98%
- Exploring thienothiadiazine dioxides as isosteric analogues of benzo- and pyridothiadiazine dioxides in the search of new AMPA and kainate receptor positive allosteric modulators 98%
Similar papers in this journal
- Stereo-specific Lasofoxifene Derivatives Reveal the Interplay between Estrogen Receptor Alpha Stability and Antagonistic Activity in ESR1 Mutant Breast Cancer Cells 93%
- Crotamiton derivative JM03 extends lifespan and improves oxidative and hypertonic stress resistance in Caenorhabditis elegans via inhibiting OSM-9 92%
- Discovery of a new class of reversible TEA-domain transcription factor inhibitors with a novel binding mode 91%
Similar papers in this journal
- A genome-scale drug discovery pipeline uncovers new therapeutic targets and a unique p97 allosteric binding site in Schistosoma mansoni 95%
- A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells 90%
- Bepridil is Potent Against SARS-CoV-2 In Vitro 90%
Similar papers in this journal
- Dual acting small-Molecule inhibitors targeting Mycobacterial DNA replication 98%
- Harnessing the Biosynthetic Diversity of Actinomycetes: Discovery of Unique Natural Products through Comparative Genomic and Metabolic Analysis 90%
- Epigenetic anti-cancer treatment with a stabilized carbocyclic Decitabine analogue 88%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.